| Name | Verinurad |
|---|---|
| Synonyms |
Verinurad
2-{[3-(4-Cyano-1-naphthyl)-4-pyridinyl]sulfanyl}-2-methylpropanoic acid RDEA3170 UNII:12WJ62D047 Propanoic acid, 2-[[3-(4-cyano-1-naphthalenyl)-4-pyridinyl]thio]-2-methyl- |
| Description | Verinurad (RDEA3170) is a highly potent and specific URAT1 inhibitor with an IC50 of 25 nM[1]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 25 nM (URAT1)[1] |
| In Vitro | Verinurad inhibits the transport activity of human URAT1 in a dose-dependent manner, at high potency with an IC50 of 25 nM [1]. |
| References |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 566.7±50.0 °C at 760 mmHg |
| Molecular Formula | C20H16N2O2S |
| Molecular Weight | 348.418 |
| Flash Point | 296.5±30.1 °C |
| Exact Mass | 348.093262 |
| LogP | 3.77 |
| Vapour Pressure | 0.0±1.6 mmHg at 25°C |
| Index of Refraction | 1.692 |
| Storage condition | -20℃ |